Remitting Long-Standing Major Depression in a Multiple Sclerosis Patient With Several Concurrent Conditions

Neuropsychiatric Disease and Treatment
doi 10.2147/ndt.s169292
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Remyelination in Multiple Sclerosis: Realizing a Long-Standing Challenge

Expert Review of Neurotherapeutics
NeuroscienceNeurologyPharmacology
2015English

Commentary: Acute Hemorrhagic Leukoencephalitis (Weston–Hurst Syndrome) in a Patient With Relapse-Remitting Multiple Sclerosis

Frontiers in Immunology
AllergyImmunology
2016English

Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis

Neurotherapeutics
NeurologyPharmacology
2017English

Immune Thrombocytopenia (ITP) in a Patient With Relapsing-Remitting Multiple Sclerosis (RRMS) Associated With B-Interferon-1α Treatment

Indian Journal of Pharmaceutical Education and Research
ToxicologyPharmaceuticsPharmacology
2018English

Cognitive Profile of Patients With Relapsing Remitting Multiple Sclerosis

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
1999English

Progressive Gray Matter Damage in Patients With Relapsing-Remitting Multiple Sclerosis

Archives of Neurology
2005English

Cognitive Impairments in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis

Multiple Sclerosis
Neurology
2008English

Natalizumab: A New Treatment for Relapsing Remitting Multiple Sclerosis

Therapeutics and Clinical Risk Management
Chemical HealthPharmacologySafetyMedicineToxicologySafety ResearchPharmaceutics
2007English

Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy